BC's Kardium raises $115 million USD for heart device technology
BC’s Kardium raises $115 million USD for heart device technology Kardium, a British Columbia-based medical device company, has secured $115 million USD from Fidelity Management and T. Rowe Price Associates. The round was led by United States-based Fidelity Management, with T. Rowe Price Associates providing follow-on investment after leading Kardium’s $40 million USD financing in 2018. The company is reportedly looking to hit the public markets in 2024. Kardium is a medical tech company that has developed a device that treats atrial fibrillation, a common heart disorder...
Source: betakit.com